U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07235813) titled 'IL-35: A Key Immunosuppressive Driver in Mycosis Fungoides Modulated by Phototherapy' on Nov. 14.
Brief Summary: Mycosis fungoides is the most common type of skin lymphoma. It develops when certain white blood cells (T cells) grow abnormally in the skin, causing red, scaly, or itchy patches. The disease is often treated with phototherapy, a light-based treatment that can control symptoms in early stages.
This study looked at a protein called interleukin-35 (IL-35), which normally helps regulate the immune system but can also suppress the body's ability to fight cancer. The investigators aimed to determine if IL-35 levels are higher...